Lymphofollicular HyperplasiaSymptoms, Doctors, Treatments, Advances & More
Lymphofollicular Hyperplasia Overview
Learn About Lymphofollicular Hyperplasia
Lymphofollicular hyperplasia is an increase in the number of cells found in a lymph node. These follicles contain normal white blood cells called lymphocytes. Your body produces more lymphocytes to help prevent bacteria, viruses, and other types of germs from entering the bloodstream. This may or may not be normal, depending on why it occurs.
Lymphadenopathy; Lymphofollicular hypertrophy
Ballad Health Medical Associates Sleep Medicine
Celso Ebeo is a Pulmonary Medicine provider practicing medicine in Greeneville, Tennessee. Dr. Ebeo is rated as a Distinguished provider by MediFind in the treatment of Lymphofollicular Hyperplasia. He is also highly rated in 50 other conditions, according to our data. His clinical expertise encompasses Obstructive Sleep Apnea, Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Pneumonia, and Advanced Bronchoscopy. Dr. Ebeo is board certified in American Board Of Internal Medicine.
SOFHA Pulmonology
Maria Garcia is a Pulmonary Medicine provider practicing medicine in Johnson City, Tennessee. Dr. Garcia is rated as a Distinguished provider by MediFind in the treatment of Lymphofollicular Hyperplasia. She is also highly rated in 47 other conditions, according to our data. Her clinical expertise encompasses Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Asthma in Children, Lung Nodules, and Advanced Bronchoscopy. Dr. Garcia is board certified in American Board Of Internal Medicine.
UT MD Anderson Cancer Center
Horiana Grosu is an Intensive Care Medicine provider practicing medicine in Houston, Texas. Dr. Grosu is rated as an Elite provider by MediFind in the treatment of Lymphofollicular Hyperplasia. She is also highly rated in 16 other conditions, according to our data. Her clinical expertise encompasses Pleural Effusion, Lymphofollicular Hyperplasia, Lung Cancer, Endoscopy, and Advanced Bronchoscopy.
Summary: This phase II trial compares the effect of intensity-modulated post-operative radiation therapy (I²-PORT) followed by standard of care therapy (chemotherapy or immunotherapy) to standard of care therapy alone in treating patients with non-small cell lung cancer (NSCLC) who have remaining lymph node cancer after surgery. Radiation therapy uses high-energy X-rays, particles, or radioactive seeds to ...
Summary: Study hypothesis is that combining the advantages of hybrid PET/MRI and the high sensitivity/specificity of 16-alpha-18F-fluoro-17-beta-estradiol(FES), a radiolabeled form of estrogen binding to functionally active ER, the investigators could obtain a reliable, non-invasive, operator-independent, one-stage imaging method for staging LumA and ER-positive Lobular tumours.
Published Date: August 05, 2025
Published By: Jatin M. Vyas, MD, PhD, Roy and Diana Vagelos Professor in Medicine, Columbia University Vagelos College of Physicians and Surgeons, Division of Infectious Diseases, Department of Medicine, New York, NY. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.
Ball JW, Dains JE, Flynn JA, Solomon BS, Stewart RW. Lymphatic system. In: Ball JW, Dains JE, Flynn JA, Solomon BS, Stewart RW, eds. Seidel's Guide to Physical Examination. 10th ed. St Louis, MO: Elsevier; 2023:chap 10.
Winter JN. Approach to the patient with lymphadenopathy or splenomegaly. In: Goldman L, Cooney KA, eds. Goldman-Cecil Medicine. 27th ed. Philadelphia, PA: Elsevier; 2024:chap 154.

